Mutagenicity of oral hypoglycaemic agents.
D000284:Administration, Oral; D000818:Animals; D001853:Bone Marrow / Q000473:pathology; D001854:Bone Marrow Cells; D002869:Chromosome Aberrations; D006224:Cricetinae; D003412:Cricetulus; D003920:Diabetes Mellitus / Q000235:genetics; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008214:Lymphocytes / Q000187:drug effects; D051379:Mice; D008811:Mice, Inbred DBA; D008861:Microsomes; D009154:Mutation; D012475:Salmonella / Q000235:genetics; D012486:Salmonella typhimurium / Q000235:genetics; D012854:Sister Chromatid Exchange / Q000187:drug effects; D013453:Sulfonylurea Compounds / Q000009:adverse effects
D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds